Clinical Pharmacology · Anti-Inflammatory and Immunosuppressive Medications

Corticosteroids

Want it in plain words first? Jump to Eli explains — the same idea, no jargon.
On this page 6 sections
  1. In 30 seconds
  2. The college version
  3. Eli explains
  4. Check yourself
  5. Quick check
  6. Study tools

In 30 seconds

Corticosteroids are synthetic hormones that mimic cortisol but are used at pharmacologic strength to shut down inflammation and immune activity across nearly every organ system. They work broadly and quickly, which makes them indispensable for flares of autoimmune disease, transplant rejection, and severe allergic or respiratory events, often as a bridge until slower-acting drugs take over. That same broad suppression is why they blunt the usual warning signs of infection even as they raise infection risk, making vigilant monitoring part of every course. This file focuses on corticosteroids as immune-modulating therapy; the deeper endocrine physiology and tapering mechanics live in the endocrine unit.

The college version

Mechanism: Shutting Down Inflammation at Its Source

Corticosteroids bind intracellular glucocorticoid receptors, and the activated complex moves into the nucleus and changes gene transcription on a massive scale. One key action is inducing a protein called annexin (lipocortin), which inhibits phospholipase A2. Because phospholipase A2 is the enzyme that liberates arachidonic acid from cell membrane phospholipids, blocking it cuts off the raw material for both downstream inflammatory pathways at once: the cyclooxygenase arm, which produces prostaglandins, and the lipoxygenase arm, which produces leukotrienes. This dual-arm shutdown is broader than NSAIDs, which only block cyclooxygenase. Corticosteroids also suppress the transcription factor NF-kB, a master switch that normally drives production of pro-inflammatory cytokines such as interleukin-1, interleukin-6, and tumor necrosis factor. With NF-kB activity dampened, the whole cytokine cascade that recruits and activates immune cells loses momentum. Corticosteroids further stabilize capillary membranes, reducing vascular permeability so less fluid and fewer inflammatory mediators leak into tissue, and they impair the adhesion molecules that let leukocytes stick to vessel walls and migrate into inflamed tissue. On lymphocytes specifically, corticosteroids cause redistribution out of the circulating blood pool into lymphoid tissue, and they can trigger apoptosis in certain lymphocyte populations. The net laboratory signature of all this is distinctive and easily misread: a complete blood count drawn during corticosteroid therapy often shows neutrophilia, not from new production but from demargination, meaning neutrophils that were loosely adhered to vessel walls are released back into circulation, alongside lymphopenia from the redistribution effect described above. A clinician unfamiliar with this pattern could mistake it for an active infection, when it may simply reflect the drug's mechanism.

Routes of Administration: Matching the Target

Corticosteroids come in systemic forms (oral and intravenous) for widespread or severe disease, but many indications respond well to more targeted delivery that limits systemic exposure. Intra-articular injection treats a single inflamed joint. Inhaled formulations control airway inflammation in asthma and chronic obstructive pulmonary disease with much less systemic absorption than an oral course. Topical preparations treat skin conditions, ophthalmic drops or ointments treat eye inflammation, and intralesional injection targets a specific skin or scar lesion. The guiding principle across all of these is to use the most targeted route that will control the disease, reserving systemic therapy for situations where the disease is widespread, systemic, or organ-threatening.

The Breadth of Immune-Mediated Indications

Few drug classes touch as many specialties. Corticosteroids treat asthma and chronic obstructive pulmonary disease exacerbations, autoimmune disease flares such as lupus and rheumatoid arthritis, solid organ transplant rejection, systemic vasculitis, inflammatory bowel disease flares, and hematologic conditions such as autoimmune hemolytic anemia or immune thrombocytopenia. In many of these settings, corticosteroids serve an induction role: they act fast to gain control of an acute flare while a slower-onset agent, such as a conventional or biologic disease-modifying drug, is started and gradually takes effect. Once the slower agent reaches full effect, the corticosteroid dose is reduced as a steroid-sparing strategy, minimizing cumulative exposure to an agent with substantial long-term adverse effects while still preserving disease control.

Adverse Effects, Infection Risk, and Monitoring

The adverse effect profile is broad, and infection risk deserves particular emphasis because corticosteroids suppress both the inflammatory response that signals infection and the immune cells that fight it. A patient on meaningful immunosuppressive exposure can have a serious infection with a blunted fever, minimal pain, or a falsely reassuring exam, so clinicians must maintain a high index of suspicion rather than relying on classic signs. At higher levels of immunosuppressive exposure, opportunistic infections become a real concern, and prophylaxis against Pneumocystis pneumonia is a standard consideration in that setting. Other important effects include hyperglycemia, which needs glucose monitoring, and bone loss, for which osteoporosis prophylaxis (calcium, vitamin D, and monitoring bone density) is appropriate with sustained exposure. Vaccination timing matters as well: ideally, indicated vaccines are given before starting significant immunosuppression, and live vaccines are generally avoided once a patient is meaningfully immunosuppressed, because a live attenuated organism can potentially cause disease in a host whose immune system cannot contain it. Ongoing monitoring typically includes tracking for signs of infection, blood glucose, blood pressure, bone health, and mood or behavioral changes, alongside periodic reassessment of whether the corticosteroid dose can be reduced.

Eli, the EliExplains learning guide

Eli explains

The same idea, in plain words

Explain it like I’m 10

Imagine your body's alarm system is a fire alarm that keeps going off, spraying water everywhere even after the fire is out. A corticosteroid is like reaching in and disconnecting the alarm's wiring in several places at once: the smoke sensor, the water pump, and the alarm bell all get quieted together. That's why it works so well on so many different kinds of "fires," from a swollen joint to a wheezing lung to a body attacking its own new transplanted organ. But here's the catch: when you disconnect the fire alarm, you also won't get a warning if a real fire starts somewhere else, like a germ sneaking in. That's why doctors watch these patients extra closely for hidden infections, keep an eye on blood sugar and bones, and make sure certain vaccines are given before the alarm system gets turned down.

Check yourself

2 review questions from the chapter. Try each one, then open the answer.

  1. A patient with a newly diagnosed autoimmune disease is started on a corticosteroid along with a slower-acting immunosuppressive drug. Explain the treatment strategy behind giving both at the same time.

    Show answer

    The corticosteroid acts as fast "induction" or bridging therapy to control the flare immediately, while the slower drug needs time to build up its effect; once the slower agent is working, the corticosteroid is tapered down as a steroid-sparing move to limit long-term exposure.

  2. A patient scheduled to begin significant immunosuppressive therapy is due for several vaccines. Explain the general timing principle for vaccination in this situation, and note the key rule about live vaccines.

    Show answer

    Whenever possible, vaccines are given before immunosuppressive therapy starts so the immune system can mount a full response; live vaccines in particular should generally be avoided once someone is meaningfully immunosuppressed, since the weakened-but-live organism could potentially cause actual disease in a body that can't control it.

Quick check

3 questions here. Answers stay hidden until you check.

Question 1 of 3

Corticosteroids inhibit phospholipase A2 through which mechanism?

Choose an answer, then check it.
Question 2 of 3

A patient on a significant corticosteroid course has a complete blood count showing neutrophilia and lymphopenia but no fever or other clear signs of illness. What most likely explains this pattern?

Choose an answer, then check it.
Question 3 of 3

Why might a clinician choose an inhaled or intra-articular corticosteroid over a systemic one when either could treat the local problem?

Choose an answer, then check it.

Keep learning

Ready to build on this? Continue to the next lesson.

Practice this lesson
Study tools & related lessonsRelated

Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.